Protagonist Therapeutics, Inc (PTGX)
Nasdaq: PTGX · CIK 0001377121 · United States
Every official Protagonist Therapeutics, Inc filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open PTGX filings
Protagonist Therapeutics, Inc documents
- Protagonist Therapeutics, Inc 10-K 2026PTGX 10-K 2026: annual report for fiscal 2026
- Protagonist Therapeutics, Inc 10-K 2025PTGX 10-K 2025: annual report for fiscal 2025
- Protagonist Therapeutics, Inc 10-K 2024PTGX 10-K 2024: annual report for fiscal 2024
- Protagonist Therapeutics, Inc 10-K 2023PTGX 10-K 2023: annual report for fiscal 2023
- Protagonist Therapeutics, Inc 10-K 2022PTGX 10-K 2022: annual report for fiscal 2022
- Protagonist Therapeutics, Inc 10-Q 2026PTGX 10-Q 2026: quarterly report for fiscal 2026
- Protagonist Therapeutics, Inc 10-Q 2025PTGX 10-Q 2025: quarterly report for fiscal 2025
- Protagonist Therapeutics, Inc 10-Q 2024PTGX 10-Q 2024: quarterly report for fiscal 2024
- Protagonist Therapeutics, Inc 10-Q 2023PTGX 10-Q 2023: quarterly report for fiscal 2023
- Protagonist Therapeutics, Inc 10-Q 2022PTGX 10-Q 2022: quarterly report for fiscal 2022
- Protagonist Therapeutics, Inc 8-K 2026PTGX 8-K 2026: current report for fiscal 2026
- Protagonist Therapeutics, Inc 8-K 2025PTGX 8-K 2025: current report for fiscal 2025
- Protagonist Therapeutics, Inc 8-K 2024PTGX 8-K 2024: current report for fiscal 2024
- Protagonist Therapeutics, Inc 8-K 2023PTGX 8-K 2023: current report for fiscal 2023
- Protagonist Therapeutics, Inc 8-K 2022PTGX 8-K 2022: current report for fiscal 2022
- Protagonist Therapeutics, Inc DEF 14A 2026PTGX DEF 14A 2026: proxy statement for fiscal 2026
- Protagonist Therapeutics, Inc DEF 14A 2025PTGX DEF 14A 2025: proxy statement for fiscal 2025
- Protagonist Therapeutics, Inc DEF 14A 2024PTGX DEF 14A 2024: proxy statement for fiscal 2024
- Protagonist Therapeutics, Inc DEF 14A 2023PTGX DEF 14A 2023: proxy statement for fiscal 2023
- Protagonist Therapeutics, Inc DEF 14A 2022PTGX DEF 14A 2022: proxy statement for fiscal 2022
- Protagonist Therapeutics, Inc Form 4 2026PTGX Form 4 2026: insider trading filing for fiscal 2026
- Protagonist Therapeutics, Inc Form 4 2025PTGX Form 4 2025: insider trading filing for fiscal 2025
- Protagonist Therapeutics, Inc Form 4 2024PTGX Form 4 2024: insider trading filing for fiscal 2024
- Protagonist Therapeutics, Inc Form 4 2023PTGX Form 4 2023: insider trading filing for fiscal 2023
- Protagonist Therapeutics, Inc Form 4 2022PTGX Form 4 2022: insider trading filing for fiscal 2022
- Protagonist Therapeutics, Inc S-1 2026PTGX S-1 2026: registration statement for fiscal 2026
- Protagonist Therapeutics, Inc S-1 2025PTGX S-1 2025: registration statement for fiscal 2025
- Protagonist Therapeutics, Inc S-1 2024PTGX S-1 2024: registration statement for fiscal 2024
- Protagonist Therapeutics, Inc S-1 2023PTGX S-1 2023: registration statement for fiscal 2023
- Protagonist Therapeutics, Inc S-1 2022PTGX S-1 2022: registration statement for fiscal 2022
- Protagonist Therapeutics, Inc 13F 2026PTGX 13F 2026: institutional holdings for fiscal 2026
- Protagonist Therapeutics, Inc 13F 2025PTGX 13F 2025: institutional holdings for fiscal 2025
- Protagonist Therapeutics, Inc 13F 2024PTGX 13F 2024: institutional holdings for fiscal 2024
- Protagonist Therapeutics, Inc 13F 2023PTGX 13F 2023: institutional holdings for fiscal 2023
- Protagonist Therapeutics, Inc 13F 2022PTGX 13F 2022: institutional holdings for fiscal 2022
More companies